RESEARCH-USE BIOSIMILAR ANTIBODY

Adecatumumab

Monoclonal antibody · IgG1

EPCAMIgG1RUO

Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status.

TARGETEPCAM
YMonoclonal antibody
CATALOGSC-BS-791
CATALOG NUMBERSC-BS-791
MOLECULAR WEIGHTApprox. 147.52 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status.

Adecatumumab is a recombinant research-use antibody directed against EPCAM.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Adecatumumab | StellaCyte